Jacky Vonderscher

Enyo Pharma Chief Executive Officer & President

Dr Jacky Vonderscher, Ph.D., founded ENYO Pharma SAS in 2014 and serves as its Chief Executive Officer and President. Dr Vonderscher has been a Consultant for Biotech companies since 2013. Dr Vonderscher is a Co-Inventor on the patents of Mycophenolic Acid Sodium salt (Myfortic(R)) and of Everolimus (Certican(R) and Affinitor(R)). He served as Senior Vice President and Head of Translation Research Sciences at Roche in the USA and Switzerland from 2010 to 2012. He also served as Senior Vice President and Head of Molecular Medicine Labs at Roche from 2008 to 2010. He is a Senior executive with a broad R&D experience in the pharmaceutical industry. He held different leading positions in R&D at Sandoz, Novartis from 1979 to 2008 prior to joining Roche. His work was acknowledged in 1995 for the successful development of Sandimmune Neoral(R). He has been an Independent Director at ObsEva SA since October 2013. He joined the EBE Board in September 2017

2018-08-31T08:43:06+00:00September 18, 2017|